(Q33589191)

28 July 2017

1 reference

title

Correlates of protection, antigen delivery and molecular epidemiology: basics for designing an HIV vaccine (English)

1 reference

28 July 2017

1 reference

Wagner R

1

1 reference

28 July 2017

Shao Y

series ordinal

2

1 reference

28 July 2017

Wolf H

series ordinal

3

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 March 1999

1 reference

28 July 2017

1 reference

28 July 2017

17

1 reference

28 July 2017

13-14

1 reference

28 July 2017

1706-1710

1 reference

Can the immune response control HIV infection?

28 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900431-9

7 January 2021

Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900431-9

7 January 2021

Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900431-9

7 January 2021

Studies on processing, particle formation, and immunogenicity of the HIV-1 gag gene product: a possible component of a HIV vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900431-9

7 January 2021

Induction of cytolytic T lymphocytes directed towards the V3 loop of the human immunodeficiency virus type 1 external glycoprotein gp120 by p55gag/V3 chimeric vaccinia viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900431-9

7 January 2021

Assembly and extracellular release of chimeric HIV-1 Pr55gag retrovirus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900431-9

7 January 2021

Construction, expression, and immunogenicity of chimeric HIV-1 virus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900431-9

7 January 2021

Increased incorporation of chimeric human immunodeficiency virus type 1 gp120 proteins into Pr55gag virus-like particles by an Epstein-Barr virus gp220/350-derived transmembrane domain

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900431-9

7 January 2021

Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900431-9

7 January 2021

Priming of class I-restricted cytotoxic T lymphocytes by vaccination with recombinant protein antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900431-9

7 January 2021

Protection against EHV-1 challenge infection in the murine model after vaccination with various formulations of recombinant glycoprotein gp14 (gB).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900431-9

7 January 2021

Safety and immunogenicity of recombinant human immunodeficiency virus-like particles in rodents and rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900431-9

7 January 2021

Cytotoxic T cells and neutralizing antibodies induced in rhesus monkeys by virus-like particle HIV vaccines in the absence of protection from SHIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900431-9

7 January 2021

Recovery of virtually full-length HIV-1 provirus of diverse subtypes from primary virus cultures using the polymerase chain reaction.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900431-9

7 January 2021

Cloning and characterization of a virtually full-length HIV type 1 genome from a subtype B'-Thai strain representing the most prevalent B-clade isolate in China

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900431-9

7 January 2021

10.1016/S0264-410X(98)00431-9

Identifiers

DOI

1 reference

28 July 2017

1 reference